Review of Etoricoxib (Arcoxia)

Review of Etoricoxib (Arcoxia)

Questions and Answers on the Review of Etoricoxib-Containing Medicines. June 2008, European Medicines Agency (EMEA). Etoricoxib should continue to be licensed for short term acute gout and other conditions. Doctors must be aware of heart and blood pressure risks before and during treatment.

Related: , , ,

|

The menu on the left will take you to other gouty pages.
As you move around the menu, this message will change to tell you what the page is about.